SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-617939
Filing Date
2016-06-09
Accepted
2016-06-09 17:09:14
Documents
6
Period of Report
2016-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d207384d6k.htm 6-K 16059
2 EX-1.1 d207384dex11.htm EX-1.1 151363
3 EX-5.1 d207384dex51.htm EX-5.1 8079
4 EX-99.1 d207384dex991.htm EX-99.1 6160
5 GRAPHIC g207384g0609072031325.jpg GRAPHIC 6196
6 GRAPHIC g207384g0609072031532.jpg GRAPHIC 6942
  Complete submission text file 0001193125-16-617939.txt   201063
Mailing Address 6 JONATHAN NETANYAHU ST. OR YEHUDA L3 60376
Business Address 6 JONATHAN NETANYAHU ST. OR YEHUDA L3 60376 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36581 | Film No.: 161706675
SIC: 2834 Pharmaceutical Preparations